A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples